Post
OSE Immunotherapeutics gets grant for anti-human SIRPA antibody for treating cancer
OSE Immunotherapeutics has been granted a patent for antibodies targeting human SIRPa, enhancing antigen presentation to T cells. The invention …
Cidara Therapeutics gets grant for conjugates for treating viral infections
Cidara Therapeutics has been granted a patent for compositions and methods for treating viral infections using conjugates containing neuraminidase inhibitors …
Synlogic gets grant for genetically engineered bacteria for treating phenylketonuria
Synlogic has been granted a patent for genetically programmed microorganisms, like bacteria, for modulating and treating diseases. The patent includes …
Abivax gets grant for antitumor pharmaceutical combination for cancer treatment
Abivax has been granted a patent for an antitumor pharmaceutical combination involving compound ABX196 and chemotherapeutic or immunotherapeutic agents for …
4D Molecular Therapeutics gets grant for recombinant aav for muscle cell infectivity with heterologous peptide
4D Molecular Therapeutics has been granted a patent for variant adeno-associated virus (AAV) capsid proteins that increase infectivity of muscle …
Abivax gets grant for antitumor pharmaceutical combination for cancer treatment
Abivax has been granted a patent for an antitumor pharmaceutical combination involving compound ABX196 and chemotherapeutic or immunotherapeutic agents for …
4D Molecular Therapeutics gets grant for recombinant aav for muscle cell infectivity with heterologous peptide
4D Molecular Therapeutics has been granted a patent for variant adeno-associated virus (AAV) capsid proteins that increase infectivity of muscle …
Atea Pharmaceuticals gets grant for treatment of covid-19 using purine nucleotide phosphoramidates
Atea Pharmaceuticals has been granted a patent for a method using purine nucleotide phosphoramidates to treat or prevent COVID-19 caused …
Spruce Biosciences gets grant for treatment of polycystic ovary syndrome with adrenal hyperandrogenism
Spruce Biosciences has patented a method for treating PCOS-FAH by administering a CRF1 antagonist. The treatment targets elevated adrenal androgens, …
Pieris Pharmaceuticals gets grant for patent granted for novel muteins derived from human lipocalin
Pieris Pharmaceuticals has been granted a patent for a novel library and muteins derived from human lipocalin 2 (Lcn2, hNGAL) …
Lantern Pharma gets grant for treatment of atypical teratoid/rhabdoid tumor using hydroxyureamethyl acylfulvene
Lantern Pharma has been granted a patent for a method to treat atypical teratoid/rhabdoid tumor by administering HydroxyUreaMethyl Acylfulvene to …
Denali Therapeutics gets grant for proteins for treating sanfilippo syndrome A
Denali Therapeutics has been granted a patent for proteins capable of crossing the blood-brain barrier and containing SGSH enzyme-Fc fusion …
Ikena Oncology gets grant for MEK inhibitors for cancer treatment
Ikena Oncology has been granted a patent for MEK inhibitors, compositions, and methods of use. The compound selection is a …
Cue Biopharma gets grant for T-cell modulatory multimeric polypeptides for immune response modulation
Cue Biopharma has developed T-cell modulatory multimeric polypeptides containing an immunomodulatory polypeptide and a Wilms tumor peptide to modulate T …
Equillium gets grant for inhibitors of cytokine activity using peptide antagonists
Equillium's patent involves peptide antagonists targeting ?c-family cytokines associated with diseases like leukemia and autoimmune disorders. The patent claims a …